$AKYA
Akoya Biosciences, Inc.

2022 Q3 Form 10-Q Financial Statement

#000155837022012682 Filed on August 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $18.85M $17.89M $16.89M
YoY Change 39.89% 36.9% 38.34%
Cost Of Revenue $7.945M $7.553M $6.798M
YoY Change 58.17% 52.99% 41.42%
Gross Profit $10.91M $10.34M $10.10M
YoY Change 29.03% 27.13% 36.34%
Gross Profit Margin 57.86% 57.79% 59.76%
Selling, General & Admin $19.92M $20.59M $18.19M
YoY Change 45.15% 104.55% 122.44%
% of Gross Profit 182.65% 199.11% 180.2%
Research & Development $5.466M $5.598M $5.714M
YoY Change 36.68% 89.96% 79.01%
% of Gross Profit 50.11% 54.13% 56.6%
Depreciation & Amortization $2.081M $1.690M $1.619M
YoY Change 350.43% 293.02% 55.52%
% of Gross Profit 19.08% 16.34% 16.04%
Operating Expenses $27.56M $26.65M $25.65M
YoY Change 43.6% 83.63% 100.3%
Operating Profit -$16.65M -$16.31M -$15.55M
YoY Change 55.07% 155.69% 187.98%
Interest Expense -$1.109M -$849.0K -$749.0K
YoY Change 45.35% 12.15% -0.27%
% of Operating Profit
Other Income/Expense, Net -$89.00K -$232.0K -$74.00K
YoY Change -29.37% 346.15% 12.12%
Pretax Income -$17.85M -$17.39M -$16.38M
YoY Change 53.52% 212.25% 102.49%
Income Tax $21.00K $106.0K $22.00K
% Of Pretax Income
Net Earnings -$17.87M -$17.50M -$16.40M
YoY Change 53.84% 214.49% 102.91%
Net Earnings / Revenue -94.8% -97.77% -97.07%
Basic Earnings Per Share -$0.47 -$0.47 -$0.44
Diluted Earnings Per Share -$0.47 -$0.47 -$0.44
COMMON SHARES
Basic Shares Outstanding 37.89M 37.61M 37.46M
Diluted Shares Outstanding 37.90M 37.61M 37.46M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.70M $87.61M $93.94M
YoY Change -32.0% -35.33% 703.58%
Cash & Equivalents $51.84M $46.88M $93.94M
Short-Term Investments $29.87M $40.73M
Other Short-Term Assets $8.297M $8.598M $9.841M
YoY Change -15.44% 19.0% 846.25%
Inventory $13.06M $13.22M $11.37M
Prepaid Expenses
Receivables $8.680M $10.47M $11.31M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $111.7M $119.9M $126.5M
YoY Change -23.28% -23.83% 426.28%
LONG-TERM ASSETS
Property, Plant & Equipment $10.49M $9.390M $7.588M
YoY Change 61.61% 55.98% -3.71%
Goodwill $18.26M $18.26M $18.26M
YoY Change 0.0% 0.0%
Intangibles $20.44M $20.80M $20.96M
YoY Change -4.36% -3.9%
Long-Term Investments
YoY Change
Other Assets $340.0K $348.0K $341.0K
YoY Change 0.59% 72.28% -84.07%
Total Long-Term Assets $64.71M $64.37M $60.66M
YoY Change 30.07% 31.55% 20.24%
TOTAL ASSETS
Total Short-Term Assets $111.7M $119.9M $126.5M
Total Long-Term Assets $64.71M $64.37M $60.66M
Total Assets $176.5M $184.3M $187.1M
YoY Change -9.7% -10.7% 151.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.172M $13.37M $11.52M
YoY Change 100.74% 173.01% 99.27%
Accrued Expenses $14.04M $11.50M $12.14M
YoY Change 63.3% 32.4% 89.36%
Deferred Revenue $5.876M $5.315M $4.892M
YoY Change 34.96% 23.98%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $593.0K $578.0K $383.0K
YoY Change 112.54% 100.69% -74.8%
Total Short-Term Liabilities $31.68M $33.78M $31.74M
YoY Change 83.13% 86.02% 54.36%
LONG-TERM LIABILITIES
Long-Term Debt $52.71M $42.57M $32.58M
YoY Change 62.88% 31.96% -3.59%
Other Long-Term Liabilities $16.16M $16.22M $15.78M
YoY Change 102.96% 112.76% 63.02%
Total Long-Term Liabilities $52.71M $42.57M $32.58M
YoY Change 62.88% 31.96% -25.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.68M $33.78M $31.74M
Total Long-Term Liabilities $52.71M $42.57M $32.58M
Total Liabilities $101.4M $93.41M $80.58M
YoY Change 74.72% 59.62% 25.55%
SHAREHOLDERS EQUITY
Retained Earnings -$147.9M -$130.0M -$112.5M
YoY Change 88.53% 94.56%
Common Stock $2.000K $2.000K $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.09M $90.85M $106.6M
YoY Change
Total Liabilities & Shareholders Equity $176.5M $184.3M $187.1M
YoY Change -9.7% -10.7% 151.25%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$17.87M -$17.50M -$16.40M
YoY Change 53.84% 214.49% 102.91%
Depreciation, Depletion And Amortization $2.081M $1.690M $1.619M
YoY Change 350.43% 293.02% 55.52%
Cash From Operating Activities -$12.17M -$13.39M -$17.93M
YoY Change -9.14% 7.79% 307.18%
INVESTING ACTIVITIES
Capital Expenditures -$3.789M -$1.564M $1.138M
YoY Change 102.08% 65.68% 25.47%
Acquisitions
YoY Change
Other Investing Activities $11.06M -$40.77M
YoY Change
Cash From Investing Activities $7.266M -$42.34M -$1.138M
YoY Change -487.52% 4384.96% 25.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.860M 8.667M -71.00K
YoY Change -22509.09% -93.67% 1675.0%
NET CHANGE
Cash From Operating Activities -12.17M -13.39M -17.93M
Cash From Investing Activities 7.266M -42.34M -1.138M
Cash From Financing Activities 9.860M 8.667M -71.00K
Net Change In Cash 4.955M -47.06M -19.14M
YoY Change -132.36% -138.08% 260.13%
FREE CASH FLOW
Cash From Operating Activities -$12.17M -$13.39M -$17.93M
Capital Expenditures -$3.789M -$1.564M $1.138M
Free Cash Flow -$8.382M -$11.82M -$19.07M
YoY Change -27.24% 3.02% 259.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1207000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2022Q2 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1590000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37766655
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37424101
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
akya Standard Service Based Warranty Terms
StandardServiceBasedWarrantyTerms
P1Y
akya Extended Service Based Warranty Terms
ExtendedServiceBasedWarrantyTerms
P1Y
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37766655
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37424101
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q2 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8596000
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6378000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31862000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11779000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-849000
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-757000
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40344
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1598000
dei Entity Registrant Name
EntityRegistrantName
Akoya Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5586242
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Campus Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
896-8401
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AKYA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37892282
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46881000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113079000
CY2021Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
197000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9066000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
40725000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10472000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9444000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
721000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5599000
CY2022Q2 us-gaap Inventory Net
InventoryNet
13218000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9014000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8598000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1508000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9277000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
858000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2728000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
119894000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
140814000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9390000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2476000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7487000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000
CY2022Q2 akya Demo Inventory Net
DemoInventoryNet
2035000
CY2021Q4 akya Demo Inventory Net
DemoInventoryNet
2548000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20799000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2476000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-232000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21150000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-306000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-118000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17389000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5569000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33766000
CY2022Q2 us-gaap Goodwill
Goodwill
18262000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13657000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000
CY2021Q4 us-gaap Goodwill
Goodwill
18262000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11687000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1546000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
348000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
344000
CY2022Q2 us-gaap Assets
Assets
184263000
CY2021Q4 us-gaap Assets
Assets
190907000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13372000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9435000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11503000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
136930000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17495000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66198000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13491000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3015000
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
578000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
272000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5315000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5563000
us-gaap Net Income Loss
NetIncomeLoss
-33894000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4484000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
33783000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27682000
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1554000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1330000
us-gaap Net Income Loss
NetIncomeLoss
-13645000
CY2021Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
245000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7850000
CY2022Q2 us-gaap Liabilities
Liabilities
93413000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-92000
CY2021Q4 us-gaap Liabilities
Liabilities
69556000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-92000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-92000
us-gaap Gross Profit
GrossProfit
15539000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37766655
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37424101
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17587000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5563000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33986000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13645000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-16399000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1545000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220941000
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1435000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217456000
CY2021Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130001000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96107000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-92000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
90850000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
184263000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
106552000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
164000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
190907000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17894000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13071000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34788000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25283000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
7553000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
4937000
us-gaap Cost Of Revenue
CostOfRevenue
14351000
us-gaap Cost Of Revenue
CostOfRevenue
9744000
CY2022Q2 us-gaap Gross Profit
GrossProfit
10341000
CY2021Q2 us-gaap Gross Profit
GrossProfit
8134000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
118257000
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q4 akya Demo Inventory Net
DemoInventoryNet
2548000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17495000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-92000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
dei Entity Central Index Key
EntityCentralIndexKey
0001711933
CY2022Q2 akya Depreciation Demo Inventory
DepreciationDemoInventory
293000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1721000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37612331
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29974811
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37538821
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16415800
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37612331
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29974811
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37538821
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16415800
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
90850000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
42565000
akya Depreciation Demo Inventory
DepreciationDemoInventory
645000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-51026000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32471000
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1190000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8082000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
125000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16308000
us-gaap Gross Profit
GrossProfit
20437000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
316000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17495000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6104000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20590000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10066000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38783000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18245000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5598000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2947000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11312000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6139000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1156000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
400000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-956000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
826000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1617000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1099000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3160000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2108000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
26649000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
14512000
us-gaap Operating Expenses
OperatingExpenses
52299000
us-gaap Operating Expenses
OperatingExpenses
27318000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33894000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15376000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37612331
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29974811
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37538821
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16415800
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17495000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5563000
us-gaap Net Income Loss
NetIncomeLoss
-33894000
us-gaap Net Income Loss
NetIncomeLoss
-13645000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-92000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-60000000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
99000
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
245000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
138553000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
70542000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
3219000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5563000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1216000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
147821000
us-gaap Profit Loss
ProfitLoss
-33894000
us-gaap Profit Loss
ProfitLoss
-13645000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3309000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2174000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
226000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
212000
us-gaap Share Based Compensation
ShareBasedCompensation
3266000
us-gaap Share Based Compensation
ShareBasedCompensation
1470000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
99000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-16000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-956000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
826000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
43000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2728000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2476000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1028000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1688000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6043000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4131000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2539000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3937000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-176000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9591000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1923000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1055000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
431000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31318000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16819000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2702000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1854000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
40774000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43476000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1854000
akya Proceeds From Issuance Initial Public Offering Net Of Offering Costs
ProceedsFromIssuanceInitialPublicOfferingNetOfOfferingCosts
138553000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
219000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
143000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
10000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
100000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
176000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113381000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17508000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47183000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135765000
us-gaap Interest Paid Net
InterestPaidNet
1290000
us-gaap Interest Paid Net
InterestPaidNet
1290000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1815000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
811000
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
1435000
akya Common Stock Issued During Period Value Conversion Of Convertible Securities
CommonStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71795000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
3219000
akya Number Of Geographic Regions For Sales
NumberOfGeographicRegionsForSales
3
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2.33
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
87606000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130001000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31318000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17894000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13071000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34788000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25283000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q2 akya Depreciation Demo Inventory
DepreciationDemoInventory
148000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
akya Depreciation Demo Inventory
DepreciationDemoInventory
253000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28938000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8139000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20799000
CY2022Q2 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
87698000
CY2022Q2 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses
92000
CY2022Q2 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
87606000
CY2022Q2 akya Number Of Marketable Debt Securities
NumberOfMarketableDebtSecurities
17
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14232000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11555000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4842000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4068000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9390000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7487000
akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2021 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2022Q2 akya Demo Inventory Gross
DemoInventoryGross
3835000
CY2021Q4 akya Demo Inventory Gross
DemoInventoryGross
3733000
CY2022Q2 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
1800000
CY2021Q4 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
1185000
CY2022Q2 akya Demo Inventory Net
DemoInventoryNet
2035000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28022000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6872000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21150000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1302000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2596000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2713000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2713000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2682000
CY2022Q2 akya Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
8793000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20799000
CY2022Q2 us-gaap Goodwill
Goodwill
18262000
CY2021Q4 us-gaap Goodwill
Goodwill
18262000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4589000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6502000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1295000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1207000
CY2022Q2 akya Accrued Inventory Purchases
AccruedInventoryPurchases
149000
CY2021Q4 akya Accrued Inventory Purchases
AccruedInventoryPurchases
1877000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5470000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3905000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11503000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13491000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
492000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
413000
CY2022Q2 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
557000
CY2021Q4 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
384000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
42565000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
32471000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37766655
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37424101
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8237869
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6709218
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
akya Employee Retention Credit Reduction To Payroll Expense
EmployeeRetentionCreditReductionToPayrollExpense
2825000
CY2021Q2 akya Employee Retention Credit Reduction To Payroll Expense
EmployeeRetentionCreditReductionToPayrollExpense
2825000
CY2021Q2 akya Employee Retention Credit Receivables
EmployeeRetentionCreditReceivables
3332000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7156285
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5116129
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
445000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17495000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5563000
us-gaap Net Income Loss
NetIncomeLoss
-33894000
us-gaap Net Income Loss
NetIncomeLoss
-13645000
CY2021Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
245000
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1435000
CY2021Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17495000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6104000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33894000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15376000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37612331
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29974811
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37538821
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16415800
akya Entity Number Of Business Activities
EntityNumberOfBusinessActivities
1
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17894000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13071000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34788000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25283000
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
14000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
20000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
806000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1516000
CY2022Q2 us-gaap Lease Cost
LeaseCost
965000
us-gaap Lease Cost
LeaseCost
1836000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1605000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3071000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2661000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2709000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2548000
CY2022Q2 akya Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2103000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14697000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2616000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12081000
CY2022Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
326000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
573000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
113000
CY2022Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1457000
CY2022Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
158000
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1299000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0624
us-gaap Operating Lease Payments
OperatingLeasePayments
1405000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
20000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
316000

Files In Submission

Name View Source Status
0001558370-22-012682-index-headers.html Edgar Link pending
0001558370-22-012682-index.html Edgar Link pending
akya-20220630_pre.xml Edgar Link unprocessable
0001558370-22-012682.txt Edgar Link pending
0001558370-22-012682-xbrl.zip Edgar Link pending
akya-20220630.xsd Edgar Link pending
akya-20220630x10q.htm Edgar Link pending
akya-20220630xex10d1.htm Edgar Link pending
akya-20220630xex10d3.htm Edgar Link pending
akya-20220630xex10d3001.jpg Edgar Link pending
akya-20220630xex10d3002.jpg Edgar Link pending
akya-20220630xex10d3003.jpg Edgar Link pending
akya-20220630xex31d1.htm Edgar Link pending
akya-20220630xex31d2.htm Edgar Link pending
akya-20220630xex32d1.htm Edgar Link pending
akya-20220630xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
akya-20220630_lab.xml Edgar Link unprocessable
akya-20220630_def.xml Edgar Link unprocessable
akya-20220630x10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
akya-20220630_cal.xml Edgar Link unprocessable